Psyence BioMed implements 1-for-6.25 reverse stock split on Jan. 14, 2026, following special resolution.
Psyence Biomedical Ltd. announced on Jan. 14, 2026, that their 1-for-6.25 share consolidation (reverse stock split) has become effective. The decision was made after shareholders approved a special resolution on April 16, 2025, allowing the Board of Directors to implement a share consolidation at a ratio of up to 1-for-50. Initially, the Board set a 1-for-7.97 consolidation ratio on May 5, 2025. Following this, a second share consolidation at a ratio of 1-for-6.25 was approved on December 4, 2025. The company's Nasdaq symbol is PBM.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments